Cardiff Oncology, Inc.

CRDF · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances) · Market Cap: $0.1B · 31 employees
522
SEC Filings
$1.35
Close 2026-09-16
31
Employees

Business Summary

Cardiff Oncology is a clinical-stage biotechnology company developing onvansertib, an oral, highly selective PLK1 inhibitor, for treatment of multiple cancers. The company targets RAS-mutated metastatic colorectal cancer (mCRC) as its lead indication, with investigator-initiated trials in mPDAC, SCLC, mTNBC, and CMML. Onvansertib is combined with standard-of-care therapeutics and supported by biomarker and ctDNA analyses to refine patient selection and assess treatment response.

Latest Stock Quote

CRDF 2026-09-16 $1.35 O:$1.35 H:$1.38 L:$1.31 Vol:1.9M VWAP:$1.3462
origin leaf: null

Next Earnings

expected 2026-11-10

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-242025-12-310001193125-26-067464EDGAR49K words
2025-02-272024-12-310000950170-25-028992EDGAR47K words
2024-02-292023-12-310001628280-24-007948EDGAR44K words
2023-03-022022-12-310001628280-23-006037EDGAR—
2022-02-242021-12-310001628280-22-003808EDGAR—
2021-02-252020-12-310001628280-21-003277EDGAR—
2020-02-272019-12-310001628280-20-002424EDGAR—
2019-03-062018-12-310001628280-19-002546EDGAR—
2018-02-262017-12-310001628280-18-002226EDGAR—
2017-03-152016-12-310001628280-17-002601EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-08-112026-06-300001193125-26-344545EDGAR16K words
2025-11-062025-09-300001193125-25-269424EDGAR14K words
2025-07-292025-06-300000950170-25-099610EDGAR14K words
2025-05-082025-03-310000950170-25-066886EDGAR12K words
2024-11-072024-09-300000950170-24-123242EDGAR14K words
2024-08-082024-06-300001628280-24-036098EDGAR11K words
2024-05-022024-03-310001628280-24-019974EDGAR10K words
2023-11-022023-09-300001628280-23-036375EDGAR14K words
2023-08-092023-06-300001628280-23-028549EDGAR14K words
2023-05-042023-03-310001628280-23-015692EDGAR—
2022-11-032022-09-300001628280-22-028164EDGAR—
2022-08-042022-06-300001628280-22-021044EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-09-140001493152-26-042506EDGAR1K words
2026-08-110001193125-26-344645EDGAR3K words
2026-07-160001193125-26-305467EDGAR1K words
2026-04-020001193125-26-140152EDGAR1K words
2026-02-250001193125-26-068668EDGAR6K words
2026-02-240001193125-26-067476EDGAR2K words
2026-01-270001193125-26-024375EDGAR2K words
2025-11-060001193125-25-269492EDGAR2K words
2025-07-290000950170-25-099631EDGAR2K words
2025-06-260001641172-25-016659EDGAR1K words

522 total filings indexed. 490 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ARGX — ARGENX SE

Tags

ras-mutated-metastatic-colorectal-cancer-(mcrc) metastatic-pancreatic-ductal-adenocarcinoma-(mpdac) small-cell-lung-cancer-(sclc) metastatic-triple-negative-breast-cancer-(mtnbc) chronic-myelomonocytic-leukemia-(cmml) recist-1.1-(response-evaluation-criteria) blinded-independent-central-review-(bicr) ctdna-biomarker-assay-for-ras-mutational-burden kras-mutant-allelic-frequency-(maf)-assessment

Company Identity

CIK0001213037
TickerCRDF
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedDE
HeadquartersSan Diego, California
Websitehttps://www.cardiffoncology.com
Listed1997-05-22

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: 5195e9ce558aa454d0d75acf7c5fc5c6c450157c5badfa1feb984d77a5d497a9
parent: 7d2dfd2f961f74bd71966e7563c37f112d0cf4cb832c012f046cc0910043e8b8
content hash: abd92ea101ccd470c5c802cf031fd022cbc47af0e80d66c2eb9a21a8a45d8d39
signed: 2026-09-28T19:00:51.477Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up CRDF using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on CRDF, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/CRDF (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.